-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Haemonetics, Maintains $88 Price Target

Benzinga·02/06/2026 10:08:58
Listen to the news
BTIG analyst Marie Thibault reiterates Haemonetics (NYSE:HAE) with a Buy and maintains $88 price target.